SCHEMBL9232012

SCHEMBL9232012

O=C1Nc2ccc(Cl)cc2C2(c3ccccc3)OCCN12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.56
PGR P06401 2/20 0.41
LRRK2 Q5S007 1/20 0.38
MAPT P10636 2/20 0.38
AKR1B1 P15121 3/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PDE7A Q13946 1/20 0.36
IDO1 P14902 1/20 0.36
BRD4 O60885 1/20 0.36
MGAM O43451 1/20 0.36
HTR1A P08908 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
HTR2A P28223 1/20 0.36
HTR7 P34969 1/20 0.36
HTR6 P50406 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
MAP3K14 Q99558 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11843453 0.94 AKR1C3 (0.50) AKR1C3PGRLRRK2MAPTAKR1B1
SCHEMBL11843263 0.93 AKR1C3 (0.51) AKR1C3PGRLRRK2MAPTAKR1B1
SCHEMBL11845930 0.91 AKR1C3 (0.50) AKR1C3PGRLRRK2MAPTAKR1B1
SCHEMBL9225503 0.85 AKR1C3 (0.47) AKR1C3PGRMAPTMEN1KMT2A
SCHEMBL11842992 0.85 BRD4 (0.40) AKR1C3LRRK2AKR1B1BRD4MGAM
SCHEMBL9231629 0.84 LMNA (0.42) AKR1C3LRRK2AKR1B1MEN1KMT2A
SCHEMBL11836827 0.83 AKR1C3 (0.44) AKR1C3PGRMAPTAKR1B1MEN1
SCHEMBL11869473 0.82 AKR1C3 (0.51) AKR1C3LRRK2AKR1B1MEN1KMT2A
SCHEMBL9202872 0.82 AKR1C3 (0.44) AKR1C3MAPTAKR1B1MEN1KMT2A
SCHEMBL9228892 0.81 LRRK2 (0.41) AKR1C3PGRLRRK2AKR1B1PDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0640087-A1 USE OF TRICYCLIC PYRIMIDINE DERIVATIVES AS ANTI-VIRAL MEDICAMENTS Roche Diagnostics GmbH (DE) 1995-03-01 EP disclosed
WO-1993023405-A1 USE OF TRICYCLIC PYRIMIDINE DERIVATIVES AS ANTI-VIRAL MEDICAMENTS BOEHRINGER MANNHEIM GMBH (DE) 1993-11-25 WO disclosed
US-3980645-A Fused quinazolinones and a process for production thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-09-14 US disclosed